Filing Details
- Accession Number:
- 0000899243-22-034092
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-10-24 21:44:31
- Reporting Period:
- 2022-10-20
- Accepted Time:
- 2022-10-24 21:44:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1880438 | An2 Therapeutics Inc. | ANTX | Pharmaceutical Preparations (2834) | 820606654 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1914503 | Eric Easom | C/O An2 Therapeutics, Inc. 1800 El Camino Real, Suite D Menlo Park CA 94027 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-10-20 | 7,262 | $16.68 | 18,889 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-10-20 | 31 | $17.15 | 18,858 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-10-21 | 11,601 | $16.29 | 7,257 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-10-21 | 2,350 | $16.69 | 4,907 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Billionaire Hedge Funds
